The latest bit of good news is out of Israel, where data show the Pfizer beyond tech shot is 94% effective in preventing a symptomatic infection.

最新的一點好消息是來自以色列，數據顯示輝瑞超越科技針劑在預防症狀性感染方面的效果高達94%。

The announcement Wednesday from the company's indicates the vaccine could significantly reduce transmission of the highly infectious disease.

該公司週三發佈的公告顯示，該疫苗可以大大減少這種高傳染性疾病的傳播。

Analysis from the live data collected between mid January and early March also showed the vaccine was 97% effective in preventing symptomatic disease, severe disease and death.

從1月中旬至3月上旬收集的活體數據分析也顯示，該疫苗對預防症狀性疾病、重症疾病和死亡的有效率為97%。

That's basically in line with the results from the Vaccines Late Stage Clinical trial released in December.

這與12月公佈的疫苗晚期臨床試驗結果基本一致。

The new data have yet to be peer reviewed, but are important because they show how the vaccine is performing well outside of clinical trials in the general population.

新的數據還沒有經過同行評審，但很重要，因為它們顯示了疫苗在普通人群的臨床試驗之外的良好表現。

The study showed Unvaccinated individuals we're 44 times more likely to develop covid 19 symptoms and 29 times more likely to die than those who received the vaccine data out of Israel's show.

研究顯示Unvaccinated個人我們44倍更有可能發展covid 19症狀和29倍更有可能死亡比那些接受疫苗數據出以色列的顯示。

Pfizer's vaccine is also proving to be effective against the highly infectious coronavirus variant first discovered in Britain.

輝瑞公司的疫苗也被證明對英國首次發現的高傳染性冠狀病毒變種有效。

Researchers are eager to see how fighters dose stacks up against another variant first discovered in South Africa.

研究人員急切地想看看戰士的劑量如何與南非首次發現的另一種變體相抗衡。

But so far too few Israelis have been exposed to that to draw conclusions.

但到目前為止，接觸到這些的以色列人太少了，無法得出結論。

Israel is leading the world in vaccination rollout, due in part to an agreement to share data with the vaccine developers.

以色列在疫苗接種推廣方面處於世界領先地位，部分原因是與疫苗開發商達成了共享數據的協議。

As of this week, around 55% of the country's nine million population have been given at least one dose of the vaccine.

截至本週，全國900萬人口中約有55%的人至少接種了一劑疫苗。

43% have received both doses, according to Israel's Health Ministry.

根據以色列衛生部的數據，43%的人接受過這兩種劑量的治療。